These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 30628708)
1. Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy. Wang X; Liao X; Yang C; Huang K; Yu T; Yu L; Han C; Zhu G; Zeng X; Liu Z; Zhou X; Qin W; Su H; Ye X; Peng T Oncol Rep; 2019 Mar; 41(3):1586-1602. PubMed ID: 30628708 [TBL] [Abstract][Full Text] [Related]
2. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma. He D; Liao S; Cai L; Huang W; Xie X; You M BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705 [TBL] [Abstract][Full Text] [Related]
4. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
5. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis. Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105 [TBL] [Abstract][Full Text] [Related]
6. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776 [TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
8. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis. Tang Y; Zhang Y; Hu X Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723 [TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5. Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092 [TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion. Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549 [No Abstract] [Full Text] [Related]
11. The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma. Wang X; Yu T; Liao X; Yang C; Han C; Zhu G; Huang K; Yu L; Qin W; Su H; Liu X; Peng T Cancer Med; 2018 Apr; 7(4):966-980. PubMed ID: 29479826 [TBL] [Abstract][Full Text] [Related]
12. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis. Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011 [TBL] [Abstract][Full Text] [Related]
13. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma. Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of mRNA expression of phospholipase C β family genes in hepatitis B virus‑associated hepatocellular carcinoma. Wang X; Huang K; Zeng X; Liu Z; Liao X; Yang C; Yu T; Han C; Zhu G; Qin W; Peng T Oncol Rep; 2019 May; 41(5):2855-2875. PubMed ID: 30896816 [TBL] [Abstract][Full Text] [Related]
15. Analysis of potential key genes in very early hepatocellular carcinoma. Wu M; Liu Z; Li X; Zhang A; Lin D; Li N World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a hub gene prognostic index for hepatocellular carcinoma. Shi Q; Meng Z; Tian XX; Wang YF; Wang WH Future Oncol; 2021 Jun; 17(17):2193-2208. PubMed ID: 33620260 [TBL] [Abstract][Full Text] [Related]
17. Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma. Xu W; Rao Q; An Y; Li M; Zhang Z PLoS One; 2018; 13(8):e0202763. PubMed ID: 30138346 [TBL] [Abstract][Full Text] [Related]
18. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma. Zhang Y; Tang Y; Guo C; Li G Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043 [TBL] [Abstract][Full Text] [Related]
19. Feature selection with the Fisher score followed by the Maximal Clique Centrality algorithm can accurately identify the hub genes of hepatocellular carcinoma. Li C; Xu J Sci Rep; 2019 Nov; 9(1):17283. PubMed ID: 31754223 [TBL] [Abstract][Full Text] [Related]
20. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis. Li L; Lei Q; Zhang S; Kong L; Qin B Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]